In 2020, the global Fluorescent In Situ Hybridization probe market was worth USD 714.2 million. In the future, the market will grow at a 6.2% CAGR between 2021-2026.
The future is set to see an increase in demand for In-vitro diagnostics (IVD) testing to diagnose various chronic diseases. The FISH probe technology’s high reliability, speed, and sensitivity drive the IVD market.
Request a PDF sample Report :- https://market.us/report/fluorescent-in-situ-hybridization-probe-market/request-sample/
Medical diagnostics using DNA probe-based diagnostics are gaining popularity for diagnosing suspected diseases caused or aggravated by bacteria and pathogens. The growth is also driven by identifying new diagnostic markets, automation of diagnostic tests, and investments in pharmaceutical research and pharmacogenomics. Market growth is also driven by the increasing prevalence of genetic disorders like Acute Lymphoblastic leukemia (ALL). According to the American Cancer Society (ACS), almost 7000 cases of ALL were identified in 2018, and there were more than 1500 deaths in the U.S.
Drivers:-
- Increased incidence of diseases with the cytogenetic basis
FISH probes are expected to be more popular due to the increasing prevalence of genetic abnormalities and cancer and the need for accurate, speedy, and sensitive prognostic procedures to validate disease status over the 2022-2029 forecast period.
- Increasing R&D Initiatives
Fluorescent In Situ hybridization (FISH) market expansion can be described as discovering new disease-specific biomarkers and pipeline products awaiting regulatory approval. This market will be further driven by increasing awareness, rising healthcare spending, and the development novel probes.
- More common genetic and chronic diseases
The industry is booming because of the growing demand for In Vitro diagnostics (IVD), testing, and targeted medicines. Unlike traditional cytogenetic (cell-gene) tests, FISH testing can detect tiny genetic changes that are usually undetectable under a microscope. These probes are often used in diagnosing, predicting, treating, and caring for genetic conditions and cancer.
Restraints:-
Virtual karyotyping, which uses thousands to millions upon an array of probes to detect copy number variations across the genome at unprecedented resolution, is a clinically affordable and cost-effective alternative to FISH panels. The market is being held back by the lack of alternative methods.
The market is expected to be constrained by the high costs of the fish probe as well as differences in regulations regarding the development and use of these probes.
This report on fluorescent in situ hybridization markets provides information about recent developments, trade regulations and import-export analyses, production analysis, and value chain optimization.
It also analyzes opportunities in terms of emerging revenue pockets, changes to market regulations, strategic growth analysis, market size, and category market growths. Application niches and dominance, product approvals. Geographic expansions.
Key Market Trends:-
- This study presents an analytical representation of the global Fluorescence In-situ Hybridization Probe industry (FISH), along with current trends to determine potential investment pockets.
- This report contains information about key drivers, limitations, and opportunities, as well as an analysis of the global Fluorescence In-situ Hybridization Probe market.
- We quantitatively analyze the Fluorescence Insitu hybridization market (FISH) from 2020 to 2027 in order to highlight its importance.
- Porter’s five force analysis shows the power of buyers in the market.
- This report provides a comprehensive global Fluorescence in Situ Hybridization Probe Market Analysis. This report focuses on the market’s competitive intensity and how it will change over time.
Recent Development:-
- Applied Spectral Imaging is a provider of biomedical image analysis solutions. In January 2019, a new product was released for fluorescence-in situ hybridization.
- This new product can perform fluorescence-in situ hybridization (FISH), imaging quickly and easily.
Key Market Players included in the report:-
- Mirus Bio LLC
- Life Science Technologies
- PerkinElmer Inc
- BioDot
- Horizon Diagnostics
- Sigma-Aldrich Corporation
- Agilent Technologies
- Abnova Corporation
- Biosearch Technologies
- Genemed Biotechnologies
- AffymetrixPanomics
- F. Hoffman-La Roche AG – Life Science
- Oxford Gene Technology
- Bio Care Medical
- EXIQON
- GSP Research Institute
Key Market Segments
Type
- mRNA
- miRNA
Application
- Research
- Clinical
- Companion Diagnostics
Frequently asked Questions to analyze the report better:-
- What has been the performance of the global FISH probe market? And what will the future hold for it?
- What are the major regional markets?
- What is the effect of COVID-19 on the global FISH probe market?
- What are the stages of the value chain?
- What are the main driving forces and challenges of the industry?
- What is the market structure for global fluorescent in situ hybridization probes (FISH), and who are the major players?
- How competitive is the industry?
Explore More Reports From our Database:-
Blockchain Technology in Healthcare Market Size | Forecast 2022-2032
Active Pharmaceutical Ingredients Market Size | Forecast to 2022-2032
Agricultural Robots Market Size, Share, Report | Forecast to 2022-2032
Flexible Packaging Market Size, Share, Trend | Forecast to 2022-2032
Roofing Materials Market Size, Price, Trends | Forecast to 2022-2032
About Market.us:
Market.US (Powered by Prudour Private Limited) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report providing firm.
Contact Details:
Global Business Development Team – Market.us
Market.us (Powered by Prudour Pvt. Ltd.)
Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States
Phone: +1 718 618 4351 (International), Phone: +91 78878 22626 (Asia)
Email: in*****@****et.us
